• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Peter Winter

Peter Winter

Articles

ARTICLES

FDA Keeps Up the Pace on New Medicine Approvals

Dec. 7, 2012
By Peter Winter
The FDA gave itself a proverbial pat on the back in its just-released Innovative Drug Approvals for FY 2012 report, which covers the period Oct. 1, 2011 to Sept. 30, 2012. The agency said that it matched its performance in FY 2011 and approved 35 new medicines during the year.
Read More

New Discoveries in Parkinson's Point to Biomarkers, Therapies

Dec. 3, 2012
By Peter Winter
Although Parkinson's disease (PD) is estimated to be the second most common neurodegenerative disorder, very little is known about its underlying cause. That could be about to change as scientists continue to drill down into the molecular machinery implicated in the disease.
Read More

New Institute Aims to Strengthen Quebec's Biopharmaceutical R&D

Nov. 30, 2012
By Peter Winter

Participating in public private partnerships to take advantage of biotechnology innovation is a business model that is rapidly gaining traction among pharmaceutical companies. These partnerships come in all sizes and flavors ranging from a focus on new technologies and pre-competitive research to speeding products through clinical trials.


Read More

New Discoveries in Parkinson's Point to Biomarkers, Therapies

Nov. 26, 2012
By Peter Winter
Although Parkinson's disease (PD) is estimated to be the second most common neurodegenerative disorder, very little is known about its underlying cause. That could be about to change as scientists continue to drill down into the molecular machinery implicated in the disease. Recent scientific discoveries are beginning to open up the potential for both the development of innovative approaches to early diagnosis and treatment.
Read More

Targeted Nanoparticle Cancer Drug Strategy Attracts Funding

Nov. 19, 2012
By Peter Winter
Developing a nanoparticle drug that promises to offer an alternative approach to chemotherapy with fewer side effects is a strategy that is attracting increasing interest in oncology circles. Among the many research groups worldwide involved in this field are Canadian researchers who have developed a drug-polymer conjugate that self-assembles into defined nanoparticles and, when injected, selectively accumulate in solid tumors. This promising research has attracted funding in order to set the technology along the road to eventual clinical trials.
Read More

Can New Diabetes Therapies Solve an Out-of-Control Epidemic?

Nov. 19, 2012
By Peter Winter
The statistics are just plain scary. New estimates released by the International Diabetes Federation (IDF) to mark World Diabetes Day 2012 last week say that 371 million people have diabetes and 187 million diabetes cases remain undiagnosed. The IDF data mean that millions of people are at risk of costly and debilitating diabetes complications, including nerve and kidney disease.
Read More

Presidential Election Result Good News for Stem Cell Sector

Nov. 12, 2012
By Peter Winter
At the beginning of his first term in office U.S. President Barack Obama overturned President George W. Bush's existing executive order that banned federal funding of human embryonic stem cells (hESC) research with the exception of a small number of existing stem cell lines.
Read More

Positive FSD Trial Results Push Palatin Shares Higher

Nov. 9, 2012
By Peter Winter
In the world of biotech's binary events where a company's stock price can swing wildly in value on the announcement of clinical results, good news always helps swing the needle in the positive direction.
Read More

Pushing Body's Repair Mode Using Regenerative Medicine

Nov. 5, 2012
By Peter Winter
The second part of our article on wound healing further examines the role of regenerative medicine – one of the exciting and promising therapeutic strategies for the treatment of wounds and other related conditions. Those new technologies are designed to push the body into wound-repair mode much faster than the current standards of care.
Read More

Coordinated Government Policies Will Foster Biotech Innovation

Nov. 5, 2012
By Peter Winter
There is no doubt that the biotechnology industry is truly global and that emerging markets have become extremely important for pharmaceutical companies. That is not surprising considering the fact that countries such as China, Brazil, Russia and India will represent 30 percent of the projected total global pharmaceutical sales of about $1.2 trillion in 2016, up from 20 percent of the total of $955 billion in 2011.
Read More
View All Articles by Peter Winter

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 12, 2025.
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • Digital globe illustrating pharma trade, tariffs

    Navigating the Trump tariffs, part two: Amgen, Biogen, others

    BioWorld
    As biopharma companies continue to roll out their first-quarter  earnings, Trump administration tariffs remain at the top of investors’ minds. While executives...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 6, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe